The Journal of Immunology · 2000 · 309 citations · 22 references
Life SciencesImmunologyMolecular BiologyImmunology Of Infectious DiseasesInnate ImmunityMolecular ImmunologyAntiviral ImmunityHuman Leukocyte Antigen SystemImmune RegulationMajor Histocompatibility ComplexNatural Killer Cell BiologyNatural Killer Cell RegulationAntigen Presentation InhibitionCell LysisHla Class I MoleculesHuman Leukocyte AntigensImmune Recognition ReceptorsMhc Antigen PresentationMhc Class I MoleculesNk Cell Activating Ligands
Human CMV has evolved multiple strategies to interfere with immune recognition of the host. A variety of mechanisms target Ag presentation by MHC class I molecules resulting in a reduced class I cell-surface expression. This down-regulation of class I molecules is expected to trigger NK cytotoxicity, which would have to be counteracted by the virus to establish long-term infection. Here we describe that the human CMV open reading frame UL40 encodes a canonical ligand for HLA-E, identical with the HLA-Cw03 signal sequence-derived peptide. Expression of UL40 in HLA-E-positive target cells conferred resistance to NK cell lysis via the CD94/NKG2A receptor. Generation of the UL40-derived HLA-E ligand was also observed in TAP-deficient cells. The presence of a functional TAP-independent HLA-E ligand in the UL40 signal sequence implicates this viral gene as an important negative regulator of NK activity.
22
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Véronique M. Braud, David Allan, Christopher A. O'Callaghan et al. · Nature · 1998 · 2.2K citations